Teva 'disappointed' by Irish consultants' boycott of its pharmaceuticals, company tells 'Post'
Teva told the Post it remains committed to working constructively with healthcare professionals across Ireland and to supporting patients through the "consistent supply of high-quality medicines."
Teva Pharmaceuticals expressed disappointment over an Irish Hospital Consultants Association (IHCA) motion endorsing a boycott of its products in Ireland. The Irish consultants' representative body passed the motion last week, urging members to avoid prescribing, administering, or using Teva's products whenever clinically appropriate alternatives exist, without compromising patient safety, continuity of treatment, or clinical outcomes.
The motion's supporters stated they would defend healthcare professionals who choose not to use Teva products for ethical reasons.
Teva, which has been producing medicines in Ireland for over 30 years, emphasized that healthcare should not be politicized, and treatment decisions should be based on clinical evidence, patient needs, and professional judgment. The company stated that any action targeting Teva's products unrelated to patient care risks undermining the principle of providing the most appropriate treatment for a patient's condition.
Teva remains committed to working constructively with Irish healthcare professionals and supporting patients through consistent supply of high-quality medicines.
The motion was proposed by Irish consultant Thomas Donnelly, who cited concerns over Israel's actions in Gaza. Donnelly, a pediatric orthopedic surgeon, stated that he could not in good conscience use Teva Pharmaceuticals products due to the possibility of indirect contributions to further bombardments. He added that clinicians should not be pressured to choose products based on political considerations rather than clinical need.
Teva Ireland is one of the largest suppliers of prescription medicines to the HSE, with one in eight prescription packs supplied to Irish pharmacies using Teva medicines.
Written by urgent.news from Jerusalem Post's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
